[
  {
    "ts": null,
    "headline": "DexCom Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "DexCom Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2da553fd17465618948b0305b9c316312e76a751cab081951638e7ed9007c2d7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750265820,
      "headline": "DexCom Inc. stock underperforms Wednesday when compared to competitors",
      "id": 135436022,
      "image": "",
      "related": "DXCM",
      "source": "MarketWatch",
      "summary": "DexCom Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2da553fd17465618948b0305b9c316312e76a751cab081951638e7ed9007c2d7"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025",
    "summary": "SAN DIEGO, June 18, 2025--DexCom, Inc., the global leader in glucose biosensing, today released its \"Dexcom State of Type 2 Report: Access and Attitudes Across the United States\" ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable insights into the perceptions around diabetes technology from more than 400 healthcare professionals and people with Type 2 diabetes across the United States.",
    "url": "https://finnhub.io/api/news?id=e649d9457a6e13ff49867c3411b91b6ece64f19d1b50fce23c3027977072bc48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750249800,
      "headline": "Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025",
      "id": 135355638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "SAN DIEGO, June 18, 2025--DexCom, Inc., the global leader in glucose biosensing, today released its \"Dexcom State of Type 2 Report: Access and Attitudes Across the United States\" ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable insights into the perceptions around diabetes technology from more than 400 healthcare professionals and people with Type 2 diabetes across the United States.",
      "url": "https://finnhub.io/api/news?id=e649d9457a6e13ff49867c3411b91b6ece64f19d1b50fce23c3027977072bc48"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom recalls more than 2 million CGM receivers for lack of audible alarm",
    "summary": "Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom received.",
    "url": "https://finnhub.io/api/news?id=1d25aafbb1ce9bacdde7da5692a955c37ab5c56c8ce18372b237c7e01740a869",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750244292,
      "headline": "Dexcom recalls more than 2 million CGM receivers for lack of audible alarm",
      "id": 135371254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom received.",
      "url": "https://finnhub.io/api/news?id=1d25aafbb1ce9bacdde7da5692a955c37ab5c56c8ce18372b237c7e01740a869"
    }
  },
  {
    "ts": null,
    "headline": "Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks",
    "summary": "Looking back on patient monitoring stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers.",
    "url": "https://finnhub.io/api/news?id=75f8bd0acf94753d4f520358ea960c60ab1bfe9be45d5ff4a738d330c7d14aad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750217614,
      "headline": "Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks",
      "id": 135355640,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Looking back on patient monitoring stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers.",
      "url": "https://finnhub.io/api/news?id=75f8bd0acf94753d4f520358ea960c60ab1bfe9be45d5ff4a738d330c7d14aad"
    }
  }
]